Clinical Trial Update: Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating continuous ketone monitoring in people with Type 1 diabetes who are using SGLT2 inhibitors. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: McGill University | Conditions: Diabetes, Type1diabetes | Phase 1 | Status: RECRUITING